Skip to main content

March 2016

 

 

academics

 

Clinical research courses

Teva Pharmaceutical Industries Ltd., announced the launch of the generic equivalent to CAMPRAL®1 (acamprosate calcium) delayed-release tablets, 333 mg, in the United States. Acamprosate calcium delayed-release tablets are used for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at the start of treatment.

Spending on programmes to control India’s three main communicable diseases malaria, tuberculosis and leprosy increased seven percent over five years while cases reported, taken together, increased 32 percent, according to an IndiaSpend analysis of government data.

(adsbygoogle = window.adsbygoogle || []).push({});

Malaria, a life-threatening disease caused by parasites that are transmitted to people through mosquitoe bites, started out as a parasite in birds, and then it evolved to colonise bats, and from there it has evolved to affect other mammals, reveals a new study.

The Reston virus, a member of the Ebola virus family which is known to circulate in domestic pigs in Asia, may acquire the few mutations necessary to cause disease in humans and to develop into a novel health threat, researchers have warned.

With the government announcing eradication of tuberculosis by 2030, a doctor has says a new 'Endobroncial Ultrasound' medical process that was introduced in India recently can contribute in faster diagnosis of the disease leading to correct treatment on time.

Job for Medical Representative in Consern Pharma

Consern Pharma Pvt. Ltd. (WHO - GMP Certified Company) Urgently requires unit head for its manufacturing unit having tablets & capsule section at ludhiana 

Post: Medical Representative

Job as Research Associate, BSL - III Assistant in Indian Veterinary Research Institute - Walk in interview

Interested and eligible candidates fulfilling all the requirements are invited to appear before the Selection committee for a walk-in-interview for the following purely temporary positions under the All India Network programme on Bluetongue ((AINP-BT) and Indo - UK /DBT-BBSRC project entitled “Development of diagnostic systems, reference collections and molecular epidemiology studies for important arboviral pathogens of livestock in India”.

Post: Research Associate,  BSL -III Assistant

Opportunity to work as IP Trainee - Pharma in Novo Nordisk

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Oral Solution, 10 mg/mL, the generic version of Vimpat® Oral Solution, 10 mg/mL of UCB, Inc. Glenmark will market this product upon receiving final approval of its Lacosamide Oral Solution, 10 mg/mL ANDA. The patent listed in the Orange Book for Vimpat® Oral Solution, 10 mg/mL is scheduled to expire on March 17, 2022.